Amanta Healthcare has filed draft red herring prospectus (DRHP) with the market regulator Securities and Exchange Board of India (SEBI). The issue size will be up to 1,25,00,000 equity shares with face value of Rs 10 each.
The company propose to utilize Rs 7,000 lakh of its net proceeds for funding capital expenditure requirements for civil construction work and towards purchase of equipment, plant and machinery for setting up new manufacturing line of SteriPort at Hariyala, Kheda, Gujarat and Rs 3,000 lakh for funding capital expenditure requirements towards purchase of equipment, plant and machinery for setting up new line for SVP at Hariyala, Kheda, Gujarat.
Amanta Healthcare, located in Ahmedabad (Gujarat) has emerged as India’s most versatile manufacturer and marketer of sterile dosages in Aseptic Blow -- Fill -- Seal (BFS) and Injection Stretch Blow Moulding (ISBM) space with well integrated operations -- F & D to full scale manufacturing & capability to develop customized solutions (containers, closures & drug delivery).
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1777.65 |
Dr. Reddys Lab | 1194.55 |
Cipla | 1465.65 |
Lupin | 2043.30 |
Zydus Lifesciences | 944.25 |
View more.. |